AIDA.US Aida Pharmaceuticals Inc

Healthcare Pharmaceuticals USA Stocks
- USD
Market cap
-
P/E
-
P/B
0.77x
ROE
-65.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2008.

Is AIDA.US undervalued?

Graham number

The Graham number of Aida Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Aida Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Aida Pharmaceuticals Inc yet.

Aida Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Aida Pharmaceuticals Inc

Aida Pharmaceuticals, Inc., together with its subsidiaries, engages in the formulation, clinical testing, registration, manufacture, sales, and marketing of pharmaceutical and genetic products in mainland China. It offers antibiotics, cardiovascular, and anti-cancer drugs. The company provides its products in the form of powder for injection; and liquid for intravenous injection, capsule, tablet, and ointment. The company provides Etimicin Sulfate, an injectable powder form,…

Full company profile